Published:01/10/2020
‘Using Phase-appropriate Delivery to Accelerate Inhaled Product Development’ is the most recent article written by Sandy Munro, Vectura’s SVP – Pharmaceutical Development, published by International Pharmaceutical Industry. Sandy explains how different inhaled product development programmes can use different platform delivery technologies at various stages of development.
He adds “To maximise the probability of success, delivery platform selection for each programme should be assessed individually so that the technical characteristics and the commercial drivers of each drug substance/medicine are evaluated on their own merits.”
You can read the full article here.